Incannex Healthcare June 2023 Quarterly Activities Report an

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report ...

Related Keywords

Adelaide , South Australia , Australia , India , United States , Delaware , Melbourne , Victoria , New Zealand , Camberwell , Australian , Joel Latham , Redomiciling Incannex , Peter Widdows , April Incannex , Drug Administration , Early Phase Clinical Research , Incannex Healthcare , Clinical Research , Iv Clinical Research , Quest Pharmaceutical Services , Nasdaq , Clarion Clinics Group Pty Ltd , Human Research Ethics Committee , Clarion Clinics Group , European Union Medicines Agency , Corporate Governance Council Principles , Disclosure Committee , Apirx Pharmaceuticals , Incannex Healthcare Inc , Obstructive Sleep Apnoea , Obstructive Sleep , Investigational New Drug , Trial Investigating , Managing Director , Clinics Group , Announces Final Results , Trial Assessing Safety , Trial Assessing , Emeritus Research , Placebo Controlled Clinical Trial , Active Pharmaceutical Ingredients , Avance Clinical , Advance Cannquit N , Renecann Products , European Union , European Medicines Agency , American Depository Shares , Listing Rule , Listing Rules , Australian Accounting Standards , Cash Flows , Governance Council , Corporate Governance Principles ,